Subgroups of Patients who Benefit from Interferon - Delaying progression or progression-free survival

Subgroups of Patients who Benefit from Interferon - Delaying progression or progression-free survival

ASHReport

2 years
171 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ruben Mesa, MD from UT Health San Antonio Cancer Center discusses subgroups of patients who benefit from interferon and delaying progression or progression-free survival at the 2017 American Society of Hematology.
Up Next Autoplay